Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes.
about
Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools.The Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus AttenuationNew insights into the pathology of podocyte loss: mitotic catastropheVasculogenesis: a crucial player in the resistance of solid tumours to radiotherapyCrosstalk in glomerular injury and repairThe CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetesThe glomerulus--a view from the outside--the podocyte.Nucleic acid aptamers: clinical applications and promising new horizonsProbing high affinity sequences of DNA aptamer against VEGF165The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.Investigating the antiproliferative activity of high affinity DNA aptamer on cancer cellsTNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α.CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?Podocyte injury damages other podocytes.The Subcellular Localisation of the Human Papillomavirus (HPV) 16 E7 Protein in Cervical Cancer Cells and Its Perturbation by RNA Aptamers.eNOS deficiency predisposes podocytes to injury in diabetes.Current progress of RNA aptamer-based therapeutics.Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.Using aptamers for cancer biomarker discovery.Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes.Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy.The role of metabolic and haemodynamic factors in podocyte injury in diabetes.Targeting chemokines in proteinuria-induced renal disease.Danger control programs cause tissue injury and remodeling.Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy.The signaling pathway of stromal cell-derived factor-1 and its role in kidney diseases.Role of chemokines in proteinuric kidney disorders.Diabetic nephropathy--emerging epigenetic mechanisms.Significance of CXCL12 in type 2 diabetes mellitus and its associated complications.Causes and pathogenesis of focal segmental glomerulosclerosis.Aptamers as targeted therapeutics: current potential and challenges.Nucleic acid aptamers in cancer research, diagnosis and therapy.Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.Biomedical Applications of DNA-Conjugated Gold Nanoparticles.Fetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling.Crosstalk between protective autophagy and NF-κB signal in high glucose-induced podocytes.RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways.Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury.
P2860
Q26752263-F52ACA6A-E5DB-4B0C-8E03-252EB567D408Q26795464-863C0A30-BA23-4E25-A20F-FD724EC1A2EAQ26991667-B5966128-4F6C-4133-B694-0B57111DFCBEQ26999217-1C5FAACE-F581-438C-9D69-49C4A919730DQ28085092-5458451F-8792-442C-AA1F-CBB8B4AB4FB4Q33399096-F3DC0D5C-BEE2-441D-B793-55C9B3ACF12FQ33960253-6DC02C24-7B32-457C-B6B1-5B30BF65E945Q34020798-1806C618-34A2-4096-8C15-2E9999D0DE92Q34028112-9FFC3A7B-2767-40C2-8867-9EB0F3211514Q34168165-FDF05019-F062-4D74-9E76-04A3D4988381Q34324354-5B1993A6-9D7C-4787-892A-A70FDAAF033FQ34558137-E79B951B-00CC-46B5-9F07-532063414EA4Q34788604-AA1BCF4F-49B7-4A7B-992C-69B5E66DB94DQ34810458-D62AB538-87A3-4AF3-8AE9-92EC1E1C1051Q35108875-EE2E6D28-EE53-4882-A2B2-3B13B8BABF09Q35895289-7F0EF241-8B71-4389-8DC8-C999F6546F17Q36352132-9C404DED-72C5-46EA-BBBA-2E986DC800CBQ36365202-435F7D30-CD0B-447F-9493-DEC03222AB3DQ36445393-4502D924-AEC5-4A7C-BFC7-4752DA6A8D5DQ36582427-C788D2D3-8248-4315-B5EF-4FB2AF6BED58Q37251105-FC654836-C6AE-4D35-934E-767BF48341D3Q37819453-D6E4F720-E9B1-4290-8B57-92E00176A980Q37838893-3BBA3D64-455A-4AAB-87A1-FA9D67F5F361Q38026076-4A189859-94DC-4598-A325-ED54DFD1DB39Q38113929-BD960457-0C21-4045-966D-B9CC6A084566Q38135118-0D1F204D-88E7-4AE6-BB5A-AB850F92F06DQ38168568-AB3DBAD0-DF49-4E74-B015-2C9D3FE1463EQ38188747-8ACA5666-4956-494C-88CA-B1F527F66059Q38227252-10D6114F-1D26-4FD3-BD73-F68742D0B70CQ38236202-AF4335FB-A73A-427F-B9F3-FC66D653A2F5Q38275115-DE6752E0-C240-47E7-B2A1-8D5F9B7086D0Q38290290-59602984-28E7-4539-B7DD-161609170810Q38308357-E35A176B-BF3A-4BAE-8DF1-633DBE5FB515Q38339945-6435C912-ABD9-4745-A248-0FCE91CBD6FFQ38428834-E749FA11-456A-49A9-BB41-15E4A793DB19Q38728691-3BC9D13C-2CDD-4F0A-8CCF-E4D384BEFA09Q38758052-8242DFDA-5D5F-4666-AE0F-8B5C8DB5332FQ38981875-D0F4DC58-DB68-4C88-A971-87637CB420B9Q39255682-FE88051A-3210-47B6-99CF-D33F139795FFQ39354612-3C1266B3-BF8F-4B7E-B2BA-9E1A1758B524
P2860
Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Podocytes produce homeostatic ...... ouse model of type 2 diabetes.
@en
Podocytes produce homeostatic ...... ouse model of type 2 diabetes.
@nl
type
label
Podocytes produce homeostatic ...... ouse model of type 2 diabetes.
@en
Podocytes produce homeostatic ...... ouse model of type 2 diabetes.
@nl
prefLabel
Podocytes produce homeostatic ...... ouse model of type 2 diabetes.
@en
Podocytes produce homeostatic ...... ouse model of type 2 diabetes.
@nl
P2093
P50
P1433
P1476
Podocytes produce homeostatic ...... mouse model of type 2 diabetes
@en
P2093
O P Kulkarni
S G Sayyed
S Klussmann
P2860
P2888
P304
P356
10.1007/S00125-009-1493-6
P577
2009-08-26T00:00:00Z